Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients

Saved in:
Bibliographic Details
Published inLeukemia Vol. 34; no. 2; pp. 656 - 661
Main Authors Mangaonkar, Abhishek A., Swoboda, David M., Coltro, Giacomo, Lasho, Terra L., Novotny, Paul J., Pophali, Prateek, Carr, Ryan M., Binder, Moritz, Finke, Christy M., Gangat, Naseema, Al-Kali, Aref, Begna, Kebede H., Reichard, Kaaren K., Ketterling, Rhett P., Al Ali, Najla H., Vafaii, Pardis, Zhang, Ling, Padron, Eric, Talati, Chetasi, Patnaik, Mrinal M.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.02.2020
Nature Publishing Group
Subjects
631/208/212
631/67/1990/1673
Adult
Aged
Aged, 80 and over
Cancer
Cancer Research
Critical Care Medicine
Female
Hematology
Humans
Intensive
Internal Medicine
Letter
Male
Medicine
Medicine & Public Health
Middle Aged
Myelodysplastic Syndromes - pathology
Myelodysplastic-Myeloproliferative Diseases - pathology
Neoplasms - pathology
Oncology
Oncology, Experimental
Patient outcomes
Treatment Outcome
Taiwan
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-019-0574-x